Skip to content
Whale Atlas — Follow the signal.
Home
FULL RECORDS
Search insider filingsAll Congress filings
MORE TOOLS
WatchlistGold IntelligencePeopleCharts & technicalsCompany financialsOfficial newsMy saved workspace
YOUR RESEARCH
HomeSearch insider filingsAll Congress filings
More research tools
ExploreGold IntelligencePeopleInvestigate an ideaCharts & technicalsMore evidenceCompany financialsOfficial newsMy research & helpWatchlistMy saved workspaceLearn the basicsHow signals workData & coverage
RESOURCES
LearnMethodologyData sources
Built on public evidence.

Primary sources. Clear reasoning.
No black boxes.

Our approach
Public research workspacev1.0

Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…

HomeSearchCongressWatchlist
© 2026 Whale AtlasFree public-filing research. Not financial advice. By using this site you agree to the Terms of Use.
FAQCompare trackersMethodologyData & correctionsTermsPrivacy
Back to Home
I

INSM

Nasdaq

INSMED Inc

Latest disclosureSeptember 11, 2026
Insider score Why 0?
0/ 100
Qualifying buys · 30d
$0

0 purchases · 55 sales

Price by TradingViewDelayed quote from TradingView, for viewing only. It does not power Whale Atlas scores or alerts. If the quote does not load, open the TradingView link.

Insider transactions 113

Limited filing history
All113Buying0Selling55Other58
Filters

Last 30 daysNo qualifying insider buying. Sales: $3.1M by 1 insider.

113 trades · March 30, 2026 – September 9, 2026Incomplete history: this shows the filings imported so far, not every filing ever made. Dates are trade dates. Filters affect this table only.

Showing the first 6 of 113 trades on this page.

Sale disclosed

David R. Brennan

Director

Common Stock

Reported value
$3.1M
Reported price
$124.00 / share
Traded September 9, 2026Filed September 11, 2026SEC filing
Sale disclosed

Melvin Md Sharoky

Director

Common Stock

Reported value
$637.65K
Reported price
$127.53 / share
Traded August 17, 2026Filed August 19, 2026SEC filing
Exercise or conversion

Roger Adsett

Chief Operating Officer

Common Stock

Value context
$1.12M
Reported price
$13.67 / share
Traded August 10, 2026Filed August 12, 2026SEC filing
Exercise or conversion

Roger Adsett

Chief Operating Officer

Common Stock

Value context
$1.31M
Reported price
$17.16 / share
Traded August 10, 2026Filed August 12, 2026SEC filing
Exercise or conversion

Roger Adsett

Chief Operating Officer

Common Stock

Value context
$2.47M
Reported price
$30.46 / share
Traded August 10, 2026Filed August 12, 2026SEC filing
Sale disclosed

Roger Adsett

Chief Operating Officer

Common Stock

Reported value
$31.96M
Reported price
$133.27 / share
Traded August 10, 2026Filed August 12, 2026SEC filing
Exercise or conversion

Roger Adsett

Chief Operating Officer

Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$13.67 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded August 10, 2026Filed August 12, 2026SEC filing
Exercise or conversion

Roger Adsett

Chief Operating Officer

Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$17.16 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded August 10, 2026Filed August 12, 2026SEC filing
Exercise or conversion

Roger Adsett

Chief Operating Officer

Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$30.46 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded August 10, 2026Filed August 12, 2026SEC filing
Exercise or conversion

Martina M.D. Flammer

Chief Medical Officer

Common Stock

Value context
$346.37K
Reported price
$18.95 / share
Traded August 6, 2026Filed August 7, 2026SEC filing
Exercise or conversion

Martina M.D. Flammer

Chief Medical Officer

Common Stock

Value context
$229.76K
Reported price
$25.83 / share
Traded August 6, 2026Filed August 7, 2026SEC filing
Sale disclosed

Martina M.D. Flammer

Chief Medical Officer

Common Stock

Reported value
$1.13M
Reported price
$127.00 / share
Traded August 6, 2026Filed August 7, 2026SEC filing
Sale disclosed

Martina M.D. Flammer

Chief Medical Officer

Common Stock

Reported value
$2.37M
Reported price
$129.40 / share
Traded August 6, 2026Filed August 7, 2026SEC filing
Exercise or conversion

Martina M.D. Flammer

Chief Medical Officer

Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$18.95 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded August 6, 2026Filed August 7, 2026SEC filing
Exercise or conversion

Martina M.D. Flammer

Chief Medical Officer

Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$25.83 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded August 6, 2026Filed August 7, 2026SEC filing
Exercise or conversion

William Lewis

Chair and CEO

Common Stock

Value context
$190.68K
Reported price
$30.46 / share
Traded July 23, 2026Filed July 24, 2026SEC filing
Exercise or conversion

William Lewis

Chair and CEO

Common Stock

Value context
$76.19K
Reported price
$17.16 / share
Traded July 23, 2026Filed July 24, 2026SEC filing
Sale disclosed

William Lewis

Chair and CEO

Common Stock

Reported value
$509.93K
Reported price
$105.62 / share
Traded July 23, 2026Filed July 24, 2026SEC filing
Sale disclosed

William Lewis

Chair and CEO

Common Stock

Reported value
$624.96K
Reported price
$106.43 / share
Traded July 23, 2026Filed July 24, 2026SEC filing
Exercise or conversion

William Lewis

Chair and CEO

Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$30.46 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded July 23, 2026Filed July 24, 2026SEC filing
Exercise or conversion

William Lewis

Chair and CEO

Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$17.16 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded July 23, 2026Filed July 24, 2026SEC filing
Exercise or conversion

William Lewis

Chair and CEO

Common Stock

Value context
$190.65K
Reported price
$30.46 / share
Traded July 9, 2026Filed July 10, 2026SEC filing
Exercise or conversion

William Lewis

Chair and CEO

Common Stock

Value context
$76.19K
Reported price
$17.16 / share
Traded July 9, 2026Filed July 10, 2026SEC filing
Sale disclosed

William Lewis

Chair and CEO

Common Stock

Reported value
$583.33K
Reported price
$116.55 / share
Traded July 9, 2026Filed July 10, 2026SEC filing
Sale disclosed

William Lewis

Chair and CEO

Common Stock

Reported value
$274.64K
Reported price
$117.62 / share
Traded July 9, 2026Filed July 10, 2026SEC filing
Sale disclosed

William Lewis

Chair and CEO

Common Stock

Reported value
$398.11K
Reported price
$118.52 / share
Traded July 9, 2026Filed July 10, 2026SEC filing
Exercise or conversion

William Lewis

Chair and CEO

Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$30.46 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded July 9, 2026Filed July 10, 2026SEC filing
Exercise or conversion

William Lewis

Chair and CEO

Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$17.16 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded July 9, 2026Filed July 10, 2026SEC filing
Exercise or conversion

Martina M.D. Flammer

Chief Medical Officer

Common Stock

Value context
$231.44K
Reported price
$29.13 / share
Traded July 6, 2026Filed July 8, 2026SEC filing
Exercise or conversion

Martina M.D. Flammer

Chief Medical Officer

Common Stock

Value context
$86.01K
Reported price
$19.74 / share
Traded July 6, 2026Filed July 8, 2026SEC filing
Sale disclosed

Martina M.D. Flammer

Chief Medical Officer

Common Stock

Reported value
$529.18K
Reported price
$109.02 / share
Traded July 6, 2026Filed July 8, 2026SEC filing
Sale disclosed

Martina M.D. Flammer

Chief Medical Officer

Common Stock

Reported value
$823.75K
Reported price
$110.60 / share
Traded July 6, 2026Filed July 8, 2026SEC filing
Exercise or conversion

Martina M.D. Flammer

Chief Medical Officer

Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$29.13 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded July 6, 2026Filed July 8, 2026SEC filing
Exercise or conversion

Martina M.D. Flammer

Chief Medical Officer

Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$19.74 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded July 6, 2026Filed July 8, 2026SEC filing
Exercise or conversion

William Lewis

Chair and CEO

Common Stock

Value context
$381.3K
Reported price
$30.46 / share
Traded June 25, 2026Filed June 26, 2026SEC filing
Exercise or conversion

William Lewis

Chair and CEO

Common Stock

Value context
$152.38K
Reported price
$17.16 / share
Traded June 25, 2026Filed June 26, 2026SEC filing
Sale disclosed

William Lewis

Chair and CEO

Common Stock

Reported value
$1.24M
Reported price
$102.34 / share
Traded June 25, 2026Filed June 26, 2026SEC filing
Sale disclosed

William Lewis

Chair and CEO

Common Stock

Reported value
$189.29K
Reported price
$103.10 / share
Traded June 25, 2026Filed June 26, 2026SEC filing
Sale disclosed

William Lewis

Chair and CEO

Common Stock

Reported value
$388.23K
Reported price
$104.28 / share
Traded June 25, 2026Filed June 26, 2026SEC filing
Sale disclosed

William Lewis

Chair and CEO

Common Stock

Reported value
$258.54K
Reported price
$105.27 / share
Traded June 25, 2026Filed June 26, 2026SEC filing
Sale disclosed

William Lewis

Chair and CEO

Common Stock

Reported value
$137.3K
Reported price
$106.27 / share
Traded June 25, 2026Filed June 26, 2026SEC filing
Exercise or conversion

William Lewis

Chair and CEO

Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$30.46 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded June 25, 2026Filed June 26, 2026SEC filing
Exercise or conversion

William Lewis

Chair and CEO

Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$17.16 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded June 25, 2026Filed June 26, 2026SEC filing
Award disclosed

Samuele Butera

SVP, GM, Global Respiratory

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded June 23, 2026Filed June 24, 2026SEC filing
Award disclosed

Samuele Butera

SVP, GM, Global Respiratory

Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded June 23, 2026Filed June 24, 2026SEC filing
Sale disclosed

Michael Alexander Smith

Chief Legal Officer

Common Stock

Reported value
$173.05K
Reported price
$95.82 / share
Traded June 22, 2026Filed June 24, 2026SEC filing
Sale disclosed

William Lewis

Chair and CEO

Common Stock

Reported value
$612.61K
Reported price
$94.03 / share
Traded June 8, 2026Filed June 10, 2026SEC filing
Sale disclosed

Roger Adsett

Chief Operating Officer

Common Stock

Reported value
$242.38K
Reported price
$102.27 / share
Traded June 3, 2026Filed June 5, 2026SEC filing
Sale disclosed

Sara Bonstein

Chief Financial Officer

Common Stock

Reported value
$245.86K
Reported price
$102.27 / share
Traded June 3, 2026Filed June 5, 2026SEC filing
Sale disclosed

Michael Alexander Smith

Chief Legal Officer

Common Stock

Reported value
$220.8K
Reported price
$102.27 / share
Traded June 3, 2026Filed June 5, 2026SEC filing
Sale disclosed

William Lewis

Chair and CEO

Common Stock

Reported value
$777.76K
Reported price
$102.27 / share
Traded June 3, 2026Filed June 5, 2026SEC filing
Sale disclosed

Martina M.D. Flammer

Chief Medical Officer

Common Stock

Reported value
$262.42K
Reported price
$102.27 / share
Traded June 3, 2026Filed June 5, 2026SEC filing
Sale disclosed

Martina M.D. Flammer

Chief Medical Officer

Common Stock

Reported value
$192.82K
Reported price
$103.78 / share
Traded June 5, 2026Filed June 5, 2026SEC filing
Sale disclosed

Michael Alexander Smith

Chief Legal Officer

Common Stock

Reported value
$666.98K
Reported price
$108.47 / share
Traded May 22, 2026Filed May 22, 2026SEC filing
Exercise or conversion

William Lewis

Chair and CEO

Common Stock

Value context
$190.65K
Reported price
$30.46 / share
Traded May 18, 2026Filed May 20, 2026SEC filing
Exercise or conversion

William Lewis

Chair and CEO

Common Stock

Value context
$76.19K
Reported price
$17.16 / share
Traded May 18, 2026Filed May 20, 2026SEC filing
Sale disclosed

William Lewis

Chair and CEO

Common Stock

Reported value
$605.91K
Reported price
$105.32 / share
Traded May 18, 2026Filed May 20, 2026SEC filing
Sale disclosed

William Lewis

Chair and CEO

Common Stock

Reported value
$1.26M
Reported price
$106.39 / share
Traded May 18, 2026Filed May 20, 2026SEC filing
Sale disclosed

William Lewis

Chair and CEO

Common Stock

Reported value
$853.09K
Reported price
$106.97 / share
Traded May 18, 2026Filed May 20, 2026SEC filing
Exercise or conversion

William Lewis

Chair and CEO

Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$30.46 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded May 18, 2026Filed May 20, 2026SEC filing
Exercise or conversion

William Lewis

Chair and CEO

Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$17.16 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded May 18, 2026Filed May 20, 2026SEC filing
Sale disclosed

Sara Bonstein

Chief Financial Officer

Common Stock

Reported value
$961.04K
Reported price
$116.18 / share
Traded May 13, 2026Filed May 15, 2026SEC filing
Award disclosed

Carol Schafer

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded May 13, 2026Filed May 15, 2026SEC filing
Sale disclosed

Roger Adsett

Chief Operating Officer

Common Stock

Reported value
$678.14K
Reported price
$116.18 / share
Traded May 13, 2026Filed May 15, 2026SEC filing
Award disclosed

Elizabeth M. Anderson

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded May 13, 2026Filed May 15, 2026SEC filing
Sale disclosed

Martina M.D. Flammer

Chief Medical Officer

Common Stock

Reported value
$504.04K
Reported price
$112.76 / share
Traded May 13, 2026Filed May 15, 2026SEC filing
Sale disclosed

Martina M.D. Flammer

Chief Medical Officer

Common Stock

Reported value
$393.15K
Reported price
$116.18 / share
Traded May 13, 2026Filed May 15, 2026SEC filing
Sale disclosed

Martina M.D. Flammer

Chief Medical Officer

Common Stock

Reported value
$1.23M
Reported price
$117.54 / share
Traded May 14, 2026Filed May 15, 2026SEC filing
Sale disclosed

Michael Alexander Smith

Chief Legal Officer

Common Stock

Reported value
$477.38K
Reported price
$116.18 / share
Traded May 13, 2026Filed May 15, 2026SEC filing
Award disclosed

Melvin Md Sharoky

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded May 13, 2026Filed May 15, 2026SEC filing
Award disclosed

David R. Brennan

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded May 13, 2026Filed May 15, 2026SEC filing
Award disclosed

Clarissa Desjardins

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded May 13, 2026Filed May 15, 2026SEC filing
Award disclosed

Leo Lee

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded May 13, 2026Filed May 15, 2026SEC filing
Sale disclosed

William Lewis

Chair and CEO

Common Stock

Reported value
$1.54M
Reported price
$116.18 / share
Traded May 13, 2026Filed May 15, 2026SEC filing
Exercise or conversion

Martina M.D. Flammer

Chief Medical Officer

Common Stock

Value context
$221.04K
Reported price
$17.07 / share
Traded May 11, 2026Filed May 13, 2026SEC filing
Sale disclosed

Martina M.D. Flammer

Chief Medical Officer

Common Stock

Reported value
$1.22M
Reported price
$100.35 / share
Traded May 11, 2026Filed May 13, 2026SEC filing
Sale disclosed

Martina M.D. Flammer

Chief Medical Officer

Common Stock

Reported value
$83.98K
Reported price
$101.18 / share
Traded May 11, 2026Filed May 13, 2026SEC filing
Exercise or conversion

Martina M.D. Flammer

Chief Medical Officer

Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$17.07 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded May 11, 2026Filed May 13, 2026SEC filing
Exercise or conversion

William Lewis

Chair and CEO

Common Stock

Value context
$190.65K
Reported price
$30.46 / share
Traded May 4, 2026Filed May 6, 2026SEC filing
Exercise or conversion

William Lewis

Chair and CEO

Common Stock

Value context
$76.19K
Reported price
$17.16 / share
Traded May 4, 2026Filed May 6, 2026SEC filing
Sale disclosed

William Lewis

Chair and CEO

Common Stock

Reported value
$58.1K
Reported price
$134.18 / share
Traded May 4, 2026Filed May 6, 2026SEC filing
Sale disclosed

William Lewis

Chair and CEO

Common Stock

Reported value
$80.97K
Reported price
$135.18 / share
Traded May 4, 2026Filed May 6, 2026SEC filing
Sale disclosed

William Lewis

Chair and CEO

Common Stock

Reported value
$728.62K
Reported price
$137.01 / share
Traded May 4, 2026Filed May 6, 2026SEC filing
Sale disclosed

William Lewis

Chair and CEO

Common Stock

Reported value
$375.12K
Reported price
$137.86 / share
Traded May 4, 2026Filed May 6, 2026SEC filing
Sale disclosed

William Lewis

Chair and CEO

Common Stock

Reported value
$173.45K
Reported price
$139.09 / share
Traded May 4, 2026Filed May 6, 2026SEC filing
Sale disclosed

William Lewis

Chair and CEO

Common Stock

Reported value
$53.19K
Reported price
$139.60 / share
Traded May 4, 2026Filed May 6, 2026SEC filing
Exercise or conversion

William Lewis

Chair and CEO

Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$30.46 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded May 4, 2026Filed May 6, 2026SEC filing
Exercise or conversion

William Lewis

Chair and CEO

Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$17.16 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded May 4, 2026Filed May 6, 2026SEC filing
Exercise or conversion

William Lewis

Chair and CEO

Common Stock

Value context
$190.65K
Reported price
$30.46 / share
Traded April 16, 2026Filed April 17, 2026SEC filing
Exercise or conversion

William Lewis

Chair and CEO

Common Stock

Value context
$76.19K
Reported price
$17.16 / share
Traded April 16, 2026Filed April 17, 2026SEC filing
Sale disclosed

William Lewis

Chair and CEO

Common Stock

Reported value
$321.16K
Reported price
$142.99 / share
Traded April 16, 2026Filed April 17, 2026SEC filing
Sale disclosed

William Lewis

Chair and CEO

Common Stock

Reported value
$772.69K
Reported price
$143.81 / share
Traded April 16, 2026Filed April 17, 2026SEC filing
Sale disclosed

William Lewis

Chair and CEO

Common Stock

Reported value
$326.21K
Reported price
$144.66 / share
Traded April 16, 2026Filed April 17, 2026SEC filing
Sale disclosed

William Lewis

Chair and CEO

Common Stock

Reported value
$120.28K
Reported price
$145.79 / share
Traded April 16, 2026Filed April 17, 2026SEC filing
Exercise or conversion

William Lewis

Chair and CEO

Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$30.46 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded April 16, 2026Filed April 17, 2026SEC filing
Exercise or conversion

William Lewis

Chair and CEO

Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$17.16 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded April 16, 2026Filed April 17, 2026SEC filing
Exercise or conversion

William Lewis

Chair and CEO

Common Stock

Value context
$190.65K
Reported price
$30.46 / share
Traded April 6, 2026Filed April 8, 2026SEC filing
Exercise or conversion

William Lewis

Chair and CEO

Common Stock

Value context
$76.19K
Reported price
$17.16 / share
Traded April 6, 2026Filed April 8, 2026SEC filing
Sale disclosed

William Lewis

Chair and CEO

Common Stock

Reported value
$127.28K
Reported price
$161.73 / share
Traded April 6, 2026Filed April 8, 2026SEC filing
Sale disclosed

William Lewis

Chair and CEO

Common Stock

Reported value
$1.38M
Reported price
$163.23 / share
Traded April 6, 2026Filed April 8, 2026SEC filing
Sale disclosed

William Lewis

Chair and CEO

Common Stock

Reported value
$235.19K
Reported price
$164.01 / share
Traded April 6, 2026Filed April 8, 2026SEC filing
Exercise or conversion

William Lewis

Chair and CEO

Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$30.46 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded April 6, 2026Filed April 8, 2026SEC filing
Exercise or conversion

William Lewis

Chair and CEO

Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$17.16 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded April 6, 2026Filed April 8, 2026SEC filing
Exercise or conversion

Roger Adsett

Chief Operating Officer

Common Stock

Value context
$1.28M
Reported price
$14.56 / share
Traded April 1, 2026Filed April 3, 2026SEC filing
Sale disclosed

Roger Adsett

Chief Operating Officer

Common Stock

Reported value
$1.1M
Reported price
$163.18 / share
Traded April 1, 2026Filed April 3, 2026SEC filing
Sale disclosed

Roger Adsett

Chief Operating Officer

Common Stock

Reported value
$3.12M
Reported price
$164.11 / share
Traded April 1, 2026Filed April 3, 2026SEC filing
Sale disclosed

Roger Adsett

Chief Operating Officer

Common Stock

Reported value
$10.28M
Reported price
$164.95 / share
Traded April 1, 2026Filed April 3, 2026SEC filing
Exercise or conversion

Roger Adsett

Chief Operating Officer

Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$14.56 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded April 1, 2026Filed April 3, 2026SEC filing
Exercise or conversion

Michael Alexander Smith

Chief Legal Officer

Common Stock

Value context
$96.43K
Reported price
$17.07 / share
Traded March 30, 2026Filed March 31, 2026SEC filing
Exercise or conversion

Michael Alexander Smith

Chief Legal Officer

Common Stock

Value context
$390.15K
Reported price
$27.89 / share
Traded March 30, 2026Filed March 31, 2026SEC filing
Sale disclosed

Michael Alexander Smith

Chief Legal Officer

Common Stock

Reported value
$2.96M
Reported price
$150.98 / share
Traded March 30, 2026Filed March 31, 2026SEC filing
Exercise or conversion

Michael Alexander Smith

Chief Legal Officer

Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$17.07 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded March 30, 2026Filed March 31, 2026SEC filing
Exercise or conversion

Michael Alexander Smith

Chief Legal Officer

Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$27.89 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded March 30, 2026Filed March 31, 2026SEC filing
Reporting insiderSecurity / transactionAmount / priceValueTraded / disclosedSource
DirectorCommon StockSale25,000$124.00 / share$3.1MSep 9Filed Sep 11 · 2d laterSEC filing
DirectorCommon StockSale5,000$127.53 / share$637.65KAug 17Filed Aug 19 · 2d laterSEC filing
Chief Operating OfficerCommon StockOption exercise or conversion82,280$13.67 / share$1.12MAug 10Filed Aug 12 · 2d laterSEC filing
Chief Operating OfficerCommon StockOption exercise or conversion76,600$17.16 / share$1.31MAug 10Filed Aug 12 · 2d laterSEC filing
Chief Operating OfficerCommon StockOption exercise or conversion80,970$30.46 / share$2.47MAug 10Filed Aug 12 · 2d laterSEC filing
Chief Operating OfficerCommon StockSale239,850$133.27 / share$31.96MAug 10Filed Aug 12 · 2d laterSEC filing
Chief Operating OfficerStock Option (right to buy)Option exercise or conversionDerivative units82,280$13.67 exercise / conversion priceNot a separate purchaseAug 10Filed Aug 12 · 2d laterSEC filing
Chief Operating OfficerStock Option (right to buy)Option exercise or conversionDerivative units76,600$17.16 exercise / conversion priceNot a separate purchaseAug 10Filed Aug 12 · 2d laterSEC filing
Chief Operating OfficerStock Option (right to buy)Option exercise or conversionDerivative units80,970$30.46 exercise / conversion priceNot a separate purchaseAug 10Filed Aug 12 · 2d laterSEC filing
Chief Medical OfficerCommon StockOption exercise or conversion10b5-118,278$18.95 / share$346.37KAug 6Filed Aug 7 · 1d laterSEC filing
Chief Medical OfficerCommon StockOption exercise or conversion10b5-18,895$25.83 / share$229.76KAug 6Filed Aug 7 · 1d laterSEC filing
Chief Medical OfficerCommon StockSale10b5-12 trades27,173avg $128.61 / share$3.49MAug 6Filed Aug 7 · 1d later
2 filings
  • 8,895 @ $127.00 · $1.13MSEC filing
  • 18,278 @ $129.40 · $2.37MSEC filing
Chief Medical OfficerStock Option (right to buy)Option exercise or conversion10b5-1Derivative units18,278$18.95 exercise / conversion priceNot a separate purchaseAug 6Filed Aug 7 · 1d laterSEC filing
Chief Medical OfficerStock Option (right to buy)Option exercise or conversion10b5-1Derivative units8,895$25.83 exercise / conversion priceNot a separate purchaseAug 6Filed Aug 7 · 1d laterSEC filing
Chair and CEOCommon StockOption exercise or conversion10b5-16,260$30.46 / share$190.68KJul 23Filed Jul 24 · 1d laterSEC filing
Chair and CEOCommon StockOption exercise or conversion10b5-14,440$17.16 / share$76.19KJul 23Filed Jul 24 · 1d laterSEC filing
Chair and CEOCommon StockSale10b5-12 trades10,700avg $106.06 / share$1.13MJul 23Filed Jul 24 · 1d later
2 filings
  • 4,828 @ $105.62 · $509.93KSEC filing
  • 5,872 @ $106.43 · $624.96KSEC filing
Chair and CEOStock Option (right to buy)Option exercise or conversion10b5-1Derivative units6,260$30.46 exercise / conversion priceNot a separate purchaseJul 23Filed Jul 24 · 1d laterSEC filing
Chair and CEOStock Option (right to buy)Option exercise or conversion10b5-1Derivative units4,440$17.16 exercise / conversion priceNot a separate purchaseJul 23Filed Jul 24 · 1d laterSEC filing
Chair and CEOCommon StockOption exercise or conversion10b5-16,259$30.46 / share$190.65KJul 9Filed Jul 10 · 1d laterSEC filing
Chair and CEOCommon StockOption exercise or conversion10b5-14,440$17.16 / share$76.19KJul 9Filed Jul 10 · 1d laterSEC filing
Chair and CEOCommon StockSale10b5-13 trades10,699avg $117.40 / share$1.26MJul 9Filed Jul 10 · 1d later
3 filings
  • 5,005 @ $116.55 · $583.33KSEC filing
  • 2,335 @ $117.62 · $274.64KSEC filing
  • 3,359 @ $118.52 · $398.11KSEC filing
Chair and CEOStock Option (right to buy)Option exercise or conversion10b5-1Derivative units6,259$30.46 exercise / conversion priceNot a separate purchaseJul 9Filed Jul 10 · 1d laterSEC filing
Chair and CEOStock Option (right to buy)Option exercise or conversion10b5-1Derivative units4,440$17.16 exercise / conversion priceNot a separate purchaseJul 9Filed Jul 10 · 1d laterSEC filing
Chief Medical OfficerCommon StockOption exercise or conversion10b5-17,945$29.13 / share$231.44KJul 6Filed Jul 8 · 2d laterSEC filing
Chief Medical OfficerCommon StockOption exercise or conversion10b5-14,357$19.74 / share$86.01KJul 6Filed Jul 8 · 2d laterSEC filing
Chief Medical OfficerCommon StockSale10b5-12 trades12,302avg $109.98 / share$1.35MJul 6Filed Jul 8 · 2d later
2 filings
  • 4,854 @ $109.02 · $529.18KSEC filing
  • 7,448 @ $110.60 · $823.75KSEC filing
Chief Medical OfficerStock Option (right to buy)Option exercise or conversion10b5-1Derivative units7,945$29.13 exercise / conversion priceNot a separate purchaseJul 6Filed Jul 8 · 2d laterSEC filing
Chief Medical OfficerStock Option (right to buy)Option exercise or conversion10b5-1Derivative units4,357$19.74 exercise / conversion priceNot a separate purchaseJul 6Filed Jul 8 · 2d laterSEC filing
Chair and CEOCommon StockOption exercise or conversion10b5-112,518$30.46 / share$381.3KJun 25Filed Jun 26 · 1d laterSEC filing
Chair and CEOCommon StockOption exercise or conversion10b5-18,880$17.16 / share$152.38KJun 25Filed Jun 26 · 1d laterSEC filing
Chair and CEOCommon StockSale10b5-15 trades21,398avg $103.32 / share$2.21MJun 25Filed Jun 26 · 1d later
5 filings
  • 12,091 @ $102.34 · $1.24MSEC filing
  • 1,836 @ $103.10 · $189.29KSEC filing
  • 3,723 @ $104.28 · $388.23KSEC filing
  • 2,456 @ $105.27 · $258.54KSEC filing
  • 1,292 @ $106.27 · $137.3KSEC filing
Chair and CEOStock Option (right to buy)Option exercise or conversion10b5-1Derivative units12,518$30.46 exercise / conversion priceNot a separate purchaseJun 25Filed Jun 26 · 1d laterSEC filing
Chair and CEOStock Option (right to buy)Option exercise or conversion10b5-1Derivative units8,880$17.16 exercise / conversion priceNot a separate purchaseJun 25Filed Jun 26 · 1d laterSEC filing
SVP, GM, Global RespiratoryCommon StockGrant or award7,342Price not reportedUnavailableJun 23Filed Jun 24 · 1d laterSEC filing
SVP, GM, Global RespiratoryStock Option (right to buy)Grant or awardDerivative units12,570Award · no purchase priceNon-cash awardJun 23Filed Jun 24 · 1d laterSEC filing
Chief Legal OfficerCommon StockSale10b5-11,806$95.82 / share$173.05KJun 22Filed Jun 24 · 2d laterSEC filing
Chair and CEOCommon StockSale10b5-16,515$94.03 / share$612.61KJun 8Filed Jun 10 · 2d laterSEC filing
Chief Operating OfficerCommon StockSale2,370$102.27 / share$242.38KJun 3Filed Jun 5 · 2d laterSEC filing
Chief Financial OfficerCommon StockSale2,404$102.27 / share$245.86KJun 3Filed Jun 5 · 2d laterSEC filing
Chief Legal OfficerCommon StockSale2,159$102.27 / share$220.8KJun 3Filed Jun 5 · 2d laterSEC filing
Chair and CEOCommon StockSale7,605$102.27 / share$777.76KJun 3Filed Jun 5 · 2d laterSEC filing
Chief Medical OfficerCommon StockSale10b5-12,566$102.27 / share$262.42KJun 3Filed Jun 5 · 2d laterSEC filing
Chief Medical OfficerCommon StockSale10b5-11,858$103.78 / share$192.82KJun 5Filed Jun 5 · 0d laterSEC filing
Chief Legal OfficerCommon StockSale10b5-16,149$108.47 / share$666.98KMay 22Filed May 22 · 0d laterSEC filing
Chair and CEOCommon StockOption exercise or conversion10b5-16,259$30.46 / share$190.65KMay 18Filed May 20 · 2d laterSEC filing
Chair and CEOCommon StockOption exercise or conversion10b5-14,440$17.16 / share$76.19KMay 18Filed May 20 · 2d laterSEC filing
Chair and CEOCommon StockSale10b5-13 trades25,564avg $106.33 / share$2.72MMay 18Filed May 20 · 2d later
3 filings
  • 5,753 @ $105.32 · $605.91KSEC filing
  • 11,836 @ $106.39 · $1.26MSEC filing
  • 7,975 @ $106.97 · $853.09KSEC filing
Chair and CEOStock Option (right to buy)Option exercise or conversion10b5-1Derivative units6,259$30.46 exercise / conversion priceNot a separate purchaseMay 18Filed May 20 · 2d laterSEC filing
Chair and CEOStock Option (right to buy)Option exercise or conversion10b5-1Derivative units4,440$17.16 exercise / conversion priceNot a separate purchaseMay 18Filed May 20 · 2d laterSEC filing
Chief Financial OfficerCommon StockSale8,272$116.18 / share$961.04KMay 13Filed May 15 · 2d laterSEC filing
DirectorCommon StockGrant or award3,305Price not reportedUnavailableMay 13Filed May 15 · 2d laterSEC filing
Chief Operating OfficerCommon StockSale5,837$116.18 / share$678.14KMay 13Filed May 15 · 2d laterSEC filing
DirectorCommon StockGrant or award3,305Price not reportedUnavailableMay 13Filed May 15 · 2d laterSEC filing
Chief Medical OfficerCommon StockSale10b5-12 trades7,854avg $114.23 / share$897.19KMay 13Filed May 15 · 2d later
2 filings
  • 4,470 @ $112.76 · $504.04KSEC filing
  • 3,384 @ $116.18 · $393.15KSEC filing
Chief Medical OfficerCommon StockSale10b5-110,479$117.54 / share$1.23MMay 14Filed May 15 · 1d laterSEC filing
Chief Legal OfficerCommon StockSale4,109$116.18 / share$477.38KMay 13Filed May 15 · 2d laterSEC filing
DirectorCommon StockGrant or award3,305Price not reportedUnavailableMay 13Filed May 15 · 2d laterSEC filing
DirectorCommon StockGrant or award3,305Price not reportedUnavailableMay 13Filed May 15 · 2d laterSEC filing
DirectorCommon StockGrant or award3,305Price not reportedUnavailableMay 13Filed May 15 · 2d laterSEC filing
DirectorCommon StockGrant or award3,305Price not reportedUnavailableMay 13Filed May 15 · 2d laterSEC filing
Chair and CEOCommon StockSale13,283$116.18 / share$1.54MMay 13Filed May 15 · 2d laterSEC filing
Chief Medical OfficerCommon StockOption exercise or conversion10b5-112,949$17.07 / share$221.04KMay 11Filed May 13 · 2d laterSEC filing
Chief Medical OfficerCommon StockSale10b5-12 trades12,949avg $100.40 / share$1.3MMay 11Filed May 13 · 2d later
2 filings
  • 12,119 @ $100.35 · $1.22MSEC filing
  • 830 @ $101.18 · $83.98KSEC filing
Chief Medical OfficerStock Option (right to buy)Option exercise or conversion10b5-1Derivative units12,949$17.07 exercise / conversion priceNot a separate purchaseMay 11Filed May 13 · 2d laterSEC filing
Chair and CEOCommon StockOption exercise or conversion10b5-16,259$30.46 / share$190.65KMay 4Filed May 6 · 2d laterSEC filing
Chair and CEOCommon StockOption exercise or conversion10b5-14,440$17.16 / share$76.19KMay 4Filed May 6 · 2d laterSEC filing
Chair and CEOCommon StockSale10b5-16 trades10,699avg $137.34 / share$1.47MMay 4Filed May 6 · 2d later
6 filings
  • 433 @ $134.18 · $58.1KSEC filing
  • 599 @ $135.18 · $80.97KSEC filing
  • 5,318 @ $137.01 · $728.62KSEC filing
  • 2,721 @ $137.86 · $375.12KSEC filing
  • 1,247 @ $139.09 · $173.45KSEC filing
  • 381 @ $139.60 · $53.19KSEC filing
Chair and CEOStock Option (right to buy)Option exercise or conversion10b5-1Derivative units6,259$30.46 exercise / conversion priceNot a separate purchaseMay 4Filed May 6 · 2d laterSEC filing
Chair and CEOStock Option (right to buy)Option exercise or conversion10b5-1Derivative units4,440$17.16 exercise / conversion priceNot a separate purchaseMay 4Filed May 6 · 2d laterSEC filing
Chair and CEOCommon StockOption exercise or conversion10b5-16,259$30.46 / share$190.65KApr 16Filed Apr 17 · 1d laterSEC filing
Chair and CEOCommon StockOption exercise or conversion10b5-14,440$17.16 / share$76.19KApr 16Filed Apr 17 · 1d laterSEC filing
Chair and CEOCommon StockSale10b5-14 trades10,699avg $143.97 / share$1.54MApr 16Filed Apr 17 · 1d later
4 filings
  • 2,246 @ $142.99 · $321.16KSEC filing
  • 5,373 @ $143.81 · $772.69KSEC filing
  • 2,255 @ $144.66 · $326.21KSEC filing
  • 825 @ $145.79 · $120.28KSEC filing
Chair and CEOStock Option (right to buy)Option exercise or conversion10b5-1Derivative units6,259$30.46 exercise / conversion priceNot a separate purchaseApr 16Filed Apr 17 · 1d laterSEC filing
Chair and CEOStock Option (right to buy)Option exercise or conversion10b5-1Derivative units4,440$17.16 exercise / conversion priceNot a separate purchaseApr 16Filed Apr 17 · 1d laterSEC filing
Chair and CEOCommon StockOption exercise or conversion10b5-16,259$30.46 / share$190.65KApr 6Filed Apr 8 · 2d laterSEC filing
Chair and CEOCommon StockOption exercise or conversion10b5-14,440$17.16 / share$76.19KApr 6Filed Apr 8 · 2d laterSEC filing
Chair and CEOCommon StockSale10b5-13 trades10,699avg $163.22 / share$1.75MApr 6Filed Apr 8 · 2d later
3 filings
  • 787 @ $161.73 · $127.28KSEC filing
  • 8,478 @ $163.23 · $1.38MSEC filing
  • 1,434 @ $164.01 · $235.19KSEC filing
Chair and CEOStock Option (right to buy)Option exercise or conversion10b5-1Derivative units6,259$30.46 exercise / conversion priceNot a separate purchaseApr 6Filed Apr 8 · 2d laterSEC filing
Chair and CEOStock Option (right to buy)Option exercise or conversion10b5-1Derivative units4,440$17.16 exercise / conversion priceNot a separate purchaseApr 6Filed Apr 8 · 2d laterSEC filing
Chief Operating OfficerCommon StockOption exercise or conversion10b5-188,060$14.56 / share$1.28MApr 1Filed Apr 3 · 2d laterSEC filing
Chief Operating OfficerCommon StockSale10b5-13 trades88,060avg $164.63 / share$14.5MApr 1Filed Apr 3 · 2d later
3 filings
  • 6,715 @ $163.18 · $1.1MSEC filing
  • 19,001 @ $164.11 · $3.12MSEC filing
  • 62,344 @ $164.95 · $10.28MSEC filing
Chief Operating OfficerStock Option (right to buy)Option exercise or conversion10b5-1Derivative units88,060$14.56 exercise / conversion priceNot a separate purchaseApr 1Filed Apr 3 · 2d laterSEC filing
Chief Legal OfficerCommon StockOption exercise or conversion10b5-15,649$17.07 / share$96.43KMar 30Filed Mar 31 · 1d laterSEC filing
Chief Legal OfficerCommon StockOption exercise or conversion10b5-113,989$27.89 / share$390.15KMar 30Filed Mar 31 · 1d laterSEC filing
Chief Legal OfficerCommon StockSale10b5-119,638$150.98 / share$2.96MMar 30Filed Mar 31 · 1d laterSEC filing
Chief Legal OfficerStock Option (right to buy)Option exercise or conversion10b5-1Derivative units5,649$17.07 exercise / conversion priceNot a separate purchaseMar 30Filed Mar 31 · 1d laterSEC filing
Chief Legal OfficerStock Option (right to buy)Option exercise or conversion10b5-1Derivative units13,989$27.89 exercise / conversion priceNot a separate purchaseMar 30Filed Mar 31 · 1d laterSEC filing

Congress transactions 3

All Congress filings
Partial sale disclosed

Insmed Incorporated - Common Stock (INSM) · Stock

The filing reports a partial sale for a joint account.

Josh Gottheimer official portraitJosh GottheimerReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
June 10, 2026
Filed July 7, 2026 · 27d laterOriginal report
Sale disclosed

Insmed Incorporated - Common Stock (INSM) · Stock

The filing reports a sale for the member.

Gilbert Cisneros official portraitGilbert CisnerosReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
October 3, 2025
Filed November 18, 2025 · 46d laterOriginal report
Partial sale disclosed

Insmed Incorporated - Common Stock (INSM) · Stock

The filing reports a partial sale for the member.

Gilbert Cisneros official portraitGilbert CisnerosReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
September 22, 2025
Filed October 10, 2025 · 18d laterOriginal report
Explore furtherTechnical lab Company financials Test a strategy Compare company

Why this buying score?

No qualifying common-equity purchases

No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.

+0 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Limited filing history · Market-wide discovery does not establish complete company history. View coverage
Source
SEC EDGAR · Form 4
Issuer CIK
0001104506
Latest public acceptance
Sep 11, 2026, 08:04 PM UTC
Score calculated
Oct 8, 2026, 12:05 AM UTC
Parser
form4-parser-1.5
Classifier
form4-classifier-1.1
Scoring methodology
insider-experimental-1.1
Availability
Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.

Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.